For citations:
Karelov A.E., Ovezov A.M., Zabolotskikh I.B., Khoronenko V.E., Abuzarova G.R., Musaeva T.S., Klypa T.V., Rodoman G.V., Alexandrov M.I., Bozhkova S.A., Boyarkov A.V., Potapov A.L., Shaimardanov I.V., Yemelyanov D.V., Ilyin S.A., Neduruyev E.V., Shevchenko N.P., Solovyov G.S., Sorokin A.S., Gamzeleva O.Yu., Kraevskaya Yu.N. Selective opioid agonist Taphalgin® as a component of postoperative analgesia in various surgical areas: “NIKITA” observational multicenter study. Head and Neck Tumors (HNT). 2024;14(2):36-47. (In Russ.) https://doi.org/10.17650/2222-1468-2024-14-2-36-47
Email this article 